OPEN END TURBO OHNE STOP-LOSS - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000LS4F7D3

Delayed Börse Stuttgart 04:03:13 29/05/2024 pm IST
2.81 EUR +2.55% Intraday chart for OPEN END TURBO OHNE STOP-LOSS - FRESENIUS MEDICAL CARE
Current month-4.20%
1 month-11.04%
Date Price Change
29/24/29 2.81 +2.55%
28/24/28 2.74 -2.49%
27/24/27 2.81 +1.08%
24/24/24 2.78 -2.11%
23/24/23 2.84 +1.43%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 04:03 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer Lang & Schwarz
WKN LS4F7D
ISINDE000LS4F7D3
Date issued 16/10/2018
Strike 65.6
Maturity Unlimited
Parity 10 : 1
Emission price 0.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.71
Lowest since issue 0.19
Spread 0.01
Spread %0.35%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.32 EUR
Average target price
39.84 EUR
Spread / Average Target
+1.33%
Consensus